Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Contact Research Site Directly
Coronado California 92118

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Contact Research Site Directly
Fresno California 93720

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Contact Research Site Directly
Fresno California 93720

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Fresno California 93720

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]

View More ▼

UPDATED

Coronado California 92118

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

UPDATED

Fresno California 93720

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

UPDATED

Pasadena California 91105

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Rialto California

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

UPDATED

Rialto California 92377

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Colorado

Contact Research Site Directly
Englewood Colorado 80113

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Contact Research Site Directly
Englewood Colorado 80113

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Englewood Colorado 80113

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]

View More ▼

UPDATED

Englewood Colorado 80113

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Florida

Gastro Florida
Clearwater Florida 33762

TARGET-NASH: A 5-year longitudinal observational study of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis

Gastro Florida
Clearwater Florida 33762

TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis

Research Center
Miami Florida 33136

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]

Contact Research Site Directly
Wellington Florida 33414

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Contact Research Site Directly
Wellington Florida 33414

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Wellington Florida 33414

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]

View More ▼

Miami Florida

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

UPDATED

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Tampa Florida

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

UPDATED

Wellington Florida 33414

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Georgia

Contact Research Site Directly
Marietta Georgia 30060

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Contact Research Site Directly
Marietta Georgia 30060

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Marietta Georgia 30060

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]

View More ▼

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Magnetic Resonance Imaging (MRI) for patients with Non-alcoholic Fatty Liver Disease

UPDATED

Atlanta Georgia 30312

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

UPDATED

Marietta Georgia 30060

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Iowa

UPDATED

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Kentucky

UPDATED

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Louisiana

UPDATED

Shreveport Louisiana 71105

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Maryland

Contact Research Site Directly
Baltimore Maryland 21202

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

NEW

Research Center
Baltimore Maryland 21202

Do you have a fatty liver? Maybe it’s time to consider a different path.

Research Center
Catonsville Maryland 21228

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]

View More ▼

UPDATED

Baltimore Maryland 21202

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

UPDATED

Catonsville Maryland 21228

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Massachusetts

Boston Massachusetts

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

UPDATED

Worcester Massachusetts 01605

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Michigan

Contact Research Site Directly
Detroit Michigan 48202

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

NEW

Research Center
Detroit Michigan 48202

Do you have a fatty liver? Maybe it’s time to consider a different path.

View More ▼

UPDATED

Novi Michigan 48377

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Mississippi

UPDATED

Jackson Mississippi 39216

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Missouri

NEW

Research Center
Kansas City Missouri 64131

Do you have a fatty liver? Maybe it’s time to consider a different path.

View More ▼

UPDATED

Kansas City Missouri 64157

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

New Hampshire

UPDATED

Lebanon New Hampshire 03756

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

New York

Research Site
Additional Locations New York

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

Research Center
Coronado New York 92118

Do you have a fatty liver? Maybe it’s time to consider a different path.[DISABLED]